ATAD2 and esophageal squamous cell carcinoma: ATAD2 interacts with a new cofactor C/EBP-β combined with TGF-β1/SMAD3 signaling pathway to promote epithelial mesenchymal transition (EMT), ultimately leading to metastasis of esophageal squamous cell carcinoma (ESCC)22.